🚀

오늘의 열정을 계속 이어가세요!

체험은 만족하셨나요? 지식 자료를 소장하고 멋진 의료인으로 성장하세요!

구경하기
Bronchodilators | 마이메르시 MyMerci
제안하기

뭔가 하고 싶은 말이 있는거야?

제안하기
닫기
컨텐츠 수정하기

컨텐츠 내용을 수정할 수 있습니다

수정하기
닫기

Bronchodilators

NCLEX Review Guide: Respiratory Pharmacology - Bronchodilators

Bronchodilator Classifications

Beta-2 Adrenergic Agonists

  • Beta-2 adrenergic agonists work by stimulating beta-2 receptors in bronchial smooth muscle, causing relaxation and bronchodilation. These medications are first-line treatments for acute bronchospasm and asthma exacerbations.
  • Classified as either short-acting (SABA) such as albuterol (Proventil, Ventolin) and levalbuterol (Xopenex), or long-acting (LABA) such as salmeterol (Serevent) and formoterol (Foradil).

Key Points

  • SABAs have onset within 5-15 minutes and duration of 4-6 hours; used for rescue therapy
  • LABAs have onset within 15-30 minutes and duration of 12+ hours; never used alone for asthma
  • Common side effects include tachycardia, tremors, nervousness, and hypokalemia

Anticholinergics

  • Anticholinergic bronchodilators function by blocking muscarinic receptors, preventing acetylcholine from binding and causing bronchial smooth muscle relaxation. These medications are particularly effective for COPD management and can provide additive effects when combined with beta agonists.
  • Examples include ipratropium bromide (Atrovent) as short-acting and tiotropium (Spiriva) as long-acting anticholinergic bronchodilators.

Key Points

  • Slower onset (30-60 minutes) than beta agonists but longer duration
  • Fewer cardiovascular side effects compared to beta agonists
  • Common side effects include dry mouth, urinary retention, and blurred vision

Methylxanthines

  • Methylxanthines (primarily theophylline) produce bronchodilation through inhibition of phosphodiesterase enzymes, leading to increased cyclic AMP and smooth muscle relaxation. These medications have a narrow therapeutic index and require careful monitoring of serum levels.
  • Examples include theophylline (Theo-24, Uniphyl) and aminophylline (IV form of theophylline).

Key Points

  • Therapeutic serum range: 10-20 mcg/mL; toxicity occurs >20 mcg/mL
  • Numerous drug interactions affect metabolism (CYP450 system)
  • Now considered third-line therapy due to side effect profile and monitoring requirements

Commonly Confused Bronchodilators

Medication Class Examples Endings/Naming Primary Use Administration
Short-Acting Beta Agonists (SABAs) Albuterol, Levalbuterol Often end in "-ol" Rescue therapy MDI, Nebulizer
Long-Acting Beta Agonists (LABAs) Salmeterol, Formoterol Often end in "-ol" Maintenance therapy MDI, DPI
Short-Acting Anticholinergics Ipratropium Often end in "-ium" COPD, additive with SABAs MDI, Nebulizer
Long-Acting Anticholinergics Tiotropium, Umeclidinium Often end in "-ium" COPD maintenance DPI, Respimat
Methylxanthines Theophylline, Aminophylline Often end in "-phylline" Third-line therapy Oral, IV (aminophylline)

SABA vs. LABA Confusion

  • Students often confuse when to use SABAs versus LABAs. LABAs should NEVER be used as monotherapy for asthma or for acute symptom relief. SABAs are for quick relief of symptoms, while LABAs are always used with inhaled corticosteroids for long-term control.

Combination Products

  • Many bronchodilators are available in combination formulations, which can cause confusion. Common combinations include LABA + inhaled corticosteroid (Advair, Symbicort) and LABA + anticholinergic (Anoro Ellipta).

Clinical Applications

Asthma Management

  • In asthma, SABAs are the primary rescue medications for acute symptoms, while maintenance therapy typically involves inhaled corticosteroids with or without LABAs. The step-wise approach increases medication intensity based on symptom control.

Clinical Scenario: Acute Asthma Exacerbation

A 22-year-old patient presents to the ED with audible wheezing, respiratory rate of 28, and SpO2 of 91% on room air. The patient reports using their albuterol inhaler 3 times in the past hour with minimal relief.

Appropriate Management:

  1. Administer oxygen to maintain SpO2 > 92%
  2. Provide continuous or frequent (every 20 minutes for 1 hour) nebulized albuterol and ipratropium
  3. Administer systemic corticosteroids (prednisone or methylprednisolone)
  4. Consider magnesium sulfate IV for severe exacerbations
  5. Monitor response to therapy with reassessment of respiratory status

COPD Management

  • In COPD, anticholinergics often play a more central role compared to asthma management. Long-acting anticholinergics (LAMAs) are frequently first-line maintenance therapy, often combined with LABAs for moderate to severe COPD.

COPD Medication Progression Memory Aid

SMART LAMP:

  • SABA (rescue therapy)
  • Move to regular bronchodilator if symptoms persist
  • Add LAMA or LABA (or combination)
  • Reinforce with dual therapy (LAMA + LABA)
  • Triple therapy (add ICS) for severe/frequent exacerbations
  • Look for improvement in symptoms and exacerbation frequency
  • Assess for need of oxygen therapy
  • Monitor for deterioration
  • Phosphosdiesterase inhibitors (roflumilast) for chronic bronchitis phenotype

Administration Techniques

  • Proper administration technique is crucial for bronchodilator efficacy. MDI technique requires coordination, while DPIs require adequate inspiratory flow. Spacers improve drug delivery for MDIs and should be recommended for most patients.

MDI Administration Steps

  1. Shake the inhaler well before use
  2. Exhale completely away from the inhaler
  3. Place mouthpiece between lips or 1-2 inches from open mouth
  4. Begin slow, deep inhalation and press down on canister
  5. Continue slow, deep inhalation
  6. Hold breath for 10 seconds
  7. Wait 1-2 minutes between puffs if multiple doses

Adverse Effects and Nursing Considerations

Beta-2 Agonist Side Effects

  • Beta-2 agonists commonly cause sympathetic nervous system stimulation effects. While beta-2 receptors are more concentrated in the lungs, these medications can affect beta-1 receptors (heart) and beta-2 receptors in other tissues.

Key Points

  • Monitor for tachycardia, palpitations, tremors, nervousness, and headache
  • Excessive use can lead to paradoxical bronchospasm
  • May cause hypokalemia, especially with high doses

WARNING: Patients using more than 1 canister of SABA per month indicate poor asthma control and increased risk of fatal asthma attack. These patients require urgent assessment and adjustment of their controller medications.

Anticholinergic Side Effects

  • Anticholinergics produce parasympathetic blockade effects, though inhaled forms have fewer systemic effects than oral anticholinergics. These medications are contraindicated in patients with narrow-angle glaucoma and should be used cautiously in those with prostatic hyperplasia.

Key Points

  • Monitor for dry mouth, urinary retention, constipation, and blurred vision
  • Advise patients to avoid getting the medication in eyes
  • Less likely to cause cardiovascular side effects than beta agonists

Methylxanthine Toxicity

  • Methylxanthines have a narrow therapeutic index, with significant risk of toxicity. Serum levels must be monitored regularly, with therapeutic range between 10-20 mcg/mL.

Key Points

  • Early toxicity (>20 mcg/mL): nausea, vomiting, tachycardia, insomnia, headache
  • Severe toxicity (>30 mcg/mL): seizures, cardiac arrhythmias, hypotension
  • Multiple drug interactions can increase theophylline levels (erythromycin, ciprofloxacin, cimetidine)

Theophylline Interactions Memory Aid

THEOPHYLLINE levels INCREASE with:

"FACT"

  • Fluoroquinolones (ciprofloxacin)
  • Alcohol (acute ingestion)
  • Cimetidine, Clarithromycin
  • Tacrine

THEOPHYLLINE levels DECREASE with:

"SPICE"

  • Smoking
  • Phenobarbital
  • Isoniazid
  • Carbamazepine
  • Enzyme inducers (rifampin)

Study Tips

Medication Classification Memory Aids

Bronchodilator Classification Memory Aid

The "BAM" of Bronchodilators:

  • Beta-2 agonists (albuterol, salmeterol) - Relax bronchioles directly
  • Anticholinergics (ipratropium, tiotropium) - Block bronchoconstriction
  • Methylxanthines (theophylline) - Multiple mechanisms

Beta Agonist Duration Memory Aid

Remember durations with "SALSA":

  • Short-Acting: Lasts Several hours (4-6)
  • All day: Long-acting (12+ hours)

Common Pitfalls

Watch Out For These Common Mistakes

  • Confusing SABA and LABA indications - SABAs for rescue, LABAs for maintenance only
  • Forgetting that LABAs should never be used as monotherapy for asthma
  • Not recognizing signs of beta agonist overuse (increasing frequency with decreasing duration of effect)
  • Overlooking the importance of proper inhaler technique in medication efficacy
  • Failing to monitor for theophylline toxicity and drug interactions

Quick Check: Bronchodilators

Test Your Knowledge

1. Albuterol is a short-acting beta agonist used for rescue therapy.

2. Tiotropium is a long-acting anticholinergic bronchodilator.

3. LABAs should never be used alone for asthma management.

4. Theophylline has a wide therapeutic index and rarely requires monitoring.

5. Anticholinergics are typically first-line for asthma attacks.

6. Beta agonists can cause tremors and tachycardia as side effects.

7. Spacers improve medication delivery with MDIs.

8. Anticholinergics work by stimulating muscarinic receptors.

Answers: 1-True, 2-True, 3-True, 4-False, 5-False, 6-True, 7-True, 8-False

Summary of Key Points

Critical Concepts

  • Bronchodilators are classified into three main groups: beta-2 agonists, anticholinergics, and methylxanthines, each with distinct mechanisms of action and side effect profiles.
  • Beta-2 agonists are further divided into short-acting (rescue) and long-acting (maintenance) medications, with critical differences in their appropriate clinical use.
  • Proper administration technique is essential for bronchodilator efficacy, with different techniques required for MDIs, DPIs, and nebulizers.
  • Monitoring for adverse effects is crucial, particularly cardiovascular effects with beta agonists and potential toxicity with methylxanthines.
  • Treatment approaches differ between asthma (where SABAs and ICS dominate) and COPD (where anticholinergics play a more central role).

Self-Assessment Checklist

I can differentiate between the three main classes of bronchodilators and their mechanisms of action.

I understand the differences between short-acting and long-acting bronchodilators and their appropriate uses.

I can identify common side effects of each bronchodilator class and appropriate nursing interventions.

I can explain proper administration techniques for different inhaler types.

I understand the role of bronchodilators in both asthma and COPD management.

I can recognize signs of bronchodilator overuse or toxicity.

I am familiar with common drug interactions, particularly with methylxanthines.

Remember: Understanding bronchodilator pharmacology is critical for respiratory patient care. These medications can be life-saving in acute situations and life-changing for chronic management. Master these concepts now, and you'll be prepared to provide excellent care to patients with respiratory conditions throughout your nursing career!

다음 이론을 계속 학습하려면 로그인하세요.

로그인하고 계속 학습
컨텐츠를 그만볼래?

필기노트, 하이라이터, 메모는 잘 쓰고 있어?

내보내줘
어떤 폴더에 저장할래?

컨텐츠 노트에는 총 0개의 폴더가 있어!

폴더 만들기
컨텐츠 만들기
만들기
신고했어요.

운영진이 검토할게요!

해당 유저를 차단했어요.

마이페이지에서 차단한 회원을 관리할 수 있어요.